Losurdo G et al. |
Role of concomitant therapy for eradication: A technical note. |
2016 |
World J. Gastroenterol. |
pmid:27784977
|
Zhou L et al. |
Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial. |
2016 |
Helicobacter |
pmid:26104022
|
Watanabe M et al. |
Saturated fatty acids and fatty acid esters promote the polymorphic transition of clarithromycin metastable form I crystal. |
2016 |
Int J Pharm |
pmid:27553780
|
Nagashima A et al. |
Clarithromycin Suppresses Chloride Channel Accessory 1 and Inhibits Interleukin-13-Induced Goblet Cell Hyperplasia in Human Bronchial Epithelial Cells. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27550358
|
Couture G et al. |
[Second case of serum sickness-like reaction to claritrhomycin]. |
2016 |
Presse Med |
pmid:27542759
|
Bugli F et al. |
In vitro effect of clarithromycin and alginate lyase against helicobacter pylori biofilm. |
2016 |
Biotechnol. Prog. |
pmid:27535356
|
Abd-Elsalam S et al. |
A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experience. |
2016 |
Medicine (Baltimore) |
pmid:27310977
|
De Francesco V et al. |
Two-week Triple Therapy with either Standard or High-dose Esomeprazole for First-line H. pylori Eradication. |
2016 |
J Gastrointestin Liver Dis |
pmid:27308644
|
Miyaki A et al. |
An assessment of the efficacy of first-line Helicobacter pylori-eradication therapy based on clarithromycin susceptibility. |
2016 |
Minerva Gastroenterol Dietol |
pmid:27304198
|
Kim JS et al. |
Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial. |
2016 |
Gut Liver |
pmid:27114421
|
Manniello MD et al. |
Aerodynamic properties, solubility and in vitro antibacterial efficacy of dry powders prepared by spray drying: Clarithromycin versus its hydrochloride salt. |
2016 |
Eur J Pharm Biopharm |
pmid:27106605
|
Fallone CA et al. |
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. |
2016 |
Gastroenterology |
pmid:27102658
|
Bilgilier C et al. |
Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients. |
2016 |
Ann. Hematol. |
pmid:27091350
|
Murakami K et al. |
Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study. |
2016 |
Gut |
pmid:26935876
|
Park JY et al. |
Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA. |
2016 |
Dig. Dis. Sci. |
pmid:26923948
|
Guirao-Arrabal E et al. |
Clarithromycin plus linezolid as a sequential therapy for implantable-cardioverter-defibrillator infection caused by coagulase-negative staphylococci. |
2016 |
Rev Esp Quimioter |
pmid:26888341
|
Trac MH et al. |
Macrolide antibiotics and the risk of ventricular arrhythmia in older adults. |
2016 |
CMAJ |
pmid:26903359
|
Mukai S et al. |
Macrolides sensitize EGFR-TKI-induced non-apoptotic cell death via blocking autophagy flux in pancreatic cancer cell lines. |
2016 |
Int. J. Oncol. |
pmid:26718641
|
Hirama T et al. |
PCR-Based Rapid Identification System Using Bridged Nucleic Acids for Detection of Clarithromycin-Resistant Mycobacterium avium-M. intracellulare Complex Isolates. |
2016 |
J. Clin. Microbiol. |
pmid:26739154
|
Radheshi E et al. |
Postmortem diagnosis of anaphylaxis in presence of decompositional changes. |
2016 |
J Forensic Leg Med |
pmid:26735898
|
Hassan ST et al. |
In vitro synergistic effect of Hibiscus sabdariffa aqueous extract in combination with standard antibiotics against Helicobacter pylori clinical isolates. |
2016 |
Pharm Biol |
pmid:26731378
|
Hollitt A et al. |
Cat scratch disease of the parotid gland. |
2016 |
Arch. Dis. Child. |
pmid:26403943
|
Oh B et al. |
The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial. |
2016 |
Helicobacter |
pmid:26395781
|
Graham DY and Gisbert JP |
Letter: clarithromycin dose for H. pylori therapy remains unresolved. |
2015 |
Aliment. Pharmacol. Ther. |
pmid:26238583
|
Navarro-Jarabo JM et al. |
Prevalence of Primary Resistance of Helicobacter pylori to Clarithromycin and Levofloxacin in Southern Spain. |
2015 |
Digestion |
pmid:26227669
|
Ufuk A et al. |
In Vitro Assessment of Uptake and Lysosomal Sequestration of Respiratory Drugs in Alveolar Macrophage Cell Line NR8383. |
2015 |
Pharm. Res. |
pmid:26224396
|
Jeong BH et al. |
Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease. |
2015 |
Am. J. Respir. Crit. Care Med. |
pmid:25393520
|
Yu T et al. |
Study on clarithromycin lactobionate based dual selector systems for the enantioseparation of basic drugs in capillary electrophoresis. |
2015 |
J Sep Sci |
pmid:26097042
|
Trotti LM et al. |
Clarithromycin in γ-aminobutyric acid-Related hypersomnolence: A randomized, crossover trial. |
2015 |
Ann. Neurol. |
pmid:26094838
|
Tai WC et al. |
Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade "A" Success Rate for First-Line Helicobacter pylori Eradication. |
2015 |
Biomed Res Int |
pmid:26090428
|
Nguyen AT et al. |
Use of Topical Besifloxacin in the Treatment of Mycobacterium chelonae Ocular Surface Infections. |
2015 |
Cornea |
pmid:26075451
|
AktaÅŸ B et al. |
The impact of amalgam dental fillings on the frequency of Helicobacter pylori infection and H. pylori eradication rates in patients treated with concomitant, quadruple, and levofloxacin-based therapies. |
2015 |
Eur J Gastroenterol Hepatol |
pmid:25919773
|
Townsell MY et al. |
Pathology in practice. Canine distemper virus disease in a dog. |
2015 |
J. Am. Vet. Med. Assoc. |
pmid:25719842
|
Scherübl H et al. |
[What is new in treating Helicobacter pylori infection?]. |
2015 |
Dtsch. Med. Wochenschr. |
pmid:25704525
|
Aoki H et al. |
Clarithromycin highly-loaded gastro-floating fine granules prepared by high-shear melt granulation can enhance the efficacy of Helicobacter pylori eradication. |
2015 |
Eur J Pharm Biopharm |
pmid:25703356
|
Baysal B et al. |
Effect of pantoprazole and Helicobacter pylori therapy on uninvestigated dyspeptic patients. |
2015 |
Turk J Gastroenterol |
pmid:25698264
|
Blix HS et al. |
Antibiotic prescriptions and cycles of Mycoplasma pneumoniae infections in Norway: can a nationwide prescription register be used for surveillance? |
2015 |
Epidemiol. Infect. |
pmid:25388750
|
Amiri M |
Impact of Helicobacter pylori Eradication Therapy on Platelet Counts in Patients With Chronic Idiopathic Thrombocytopenic Purpura. |
2015 |
Glob J Health Sci |
pmid:26925898
|
Haghi M et al. |
Immunomodulatory effects of a low-dose clarithromycin-based macrolide solution pressurised metered dose inhaler. |
2015 |
Pharm. Res. |
pmid:25537341
|
Li DQ et al. |
Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4. |
2015 |
CMAJ |
pmid:25534598
|
Montes M et al. |
Helicobacter pylori Infection in Children. Antimicrobial Resistance and Treatment Response. |
2015 |
Helicobacter |
pmid:25382231
|
Park JB et al. |
Modulation of microenvironmental pH and utilization of alkalizers in crystalline solid dispersion for enhanced solubility and stability of clarithromicin. |
2015 |
Arch. Pharm. Res. |
pmid:25213008
|
Anton E et al. |
Randomized Trial of Clarithromycin for Mediterranean Spotted Fever. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26711765
|
Winters N et al. |
Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment. |
2015 |
Eur. Respir. J. |
pmid:26381514
|
Parra D et al. |
In vitro efficacy of daptomycin and teicoplanin combined with ethanol, clarithromycin or gentamicin as catheter lock solutions. |
2015 |
BMC Microbiol. |
pmid:26518881
|
Xing J et al. |
The application of high-resolution mass spectrometry-based data-mining tools in tandem to metabolite profiling of a triple drug combination in humans. |
2015 |
Anal. Chim. Acta |
pmid:26515003
|
Demirci H et al. |
Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection. |
2015 |
Turk J Gastroenterol |
pmid:26510082
|
Bérard A et al. |
Use of macrolides during pregnancy and the risk of birth defects: a population-based study. |
2015 |
Pharmacoepidemiol Drug Saf |
pmid:26513406
|
Agrawal V et al. |
A Case of Hypotension and Bradycardia Precipitated by Drug Interaction of Clarithromycin and Calcium-Channel Blocker. |
2015 |
J Am Geriatr Soc |
pmid:26389998
|
Glocker EO |
The Need for Resistance Surveillance and Antimicrobial Susceptibility Testing of Helicobacter pylori. |
2015 |
Digestion |
pmid:26372776
|